BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS

Clinical trials for BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS explained in plain language.

Never miss a new study

Get alerted when new BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS trials appear

Sign up with your email to follow new studies for BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to make stem cell transplants safer for blood cancer patients

Disease control Recruiting now

This Phase 2 trial is testing a stem cell transplant from a donor for people with various blood cancers and bone marrow disorders. The transplant uses strong chemotherapy or radiation to wipe out the diseased marrow, then replaces it with healthy donor cells. A new combination of…

Matched conditions: BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS

Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS

Get alerted when new BIPHENOTYPIC/UNDIFFERENTIATED/PROLYMPHOCYTIC LEUKEMIAS trials appear

New drug combo aims to make stem cell transplants safer for blood cancer patients